Published in AIDS Weekly, September 19th, 2005
"Recombinant human GH (rhGH) reduces excess accumulation of intra-abdominal adipose tissue (IAT) in lipodystrophic HIV-infected adults, whereas data in pediatric patients are lacking.
"The objective of this study was to assess the efficacy of rhGH treatment on lipodystrophy in HIV-infected adolescents. The study is a prospective, 24-week open-label study of rhGH," scientists writing in the The Journal of Clinical Endocrinology and Metabolism report.
"The study was conducted at a referral center for pediatric HIV infection. Eight HIV-infected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.